Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-157 | THZ1 | 0.01 | 1.0809 | -0.03294 |
| MDA-MB-134-VI | GSK2334470 | 0.00316227766017 | 0.8810 | -0.03294 |
| MDA-MB-134-VI | RO-3306 | 0.01 | 0.6687 | -0.03292 |
| MDA-MB-134-VI | Ribociclib | 0.316227766017 | 0.3427 | -0.03287 |
| MDA-MB-134-VI | GSK2334470 | 0.01 | 0.5294 | -0.03283 |
| MDA-MB-134-VI | RO-3306 | 1.0 | 1.3733 | -0.03283 |
| HCC1428 | THZ1 | 0.001 | 1.3270 | -0.03281 |
| HCC1428 | THZ1 | 0.0001 | 1.1528 | -0.03280 |
| MDA-MB-157 | Alvocidib | 0.000316227766017 | 1.1795 | -0.03277 |
| MDA-MB-134-VI | SHP099 | 0.01 | 0.7589 | -0.03273 |
| HCC1428 | AZD5363 | 3.16227766 | 0.8183 | -0.03269 |
| HCC1428 | RO-3306 | 0.1 | 0.8183 | -0.03269 |
| MDA-MB-134-VI | AZD6738 | 0.00316227766017 | 1.1220 | -0.03268 |
| MDA-MB-134-VI | AZD5363 | 0.01 | 1.2355 | -0.03264 |
| MDA-MB-134-VI | Alvocidib | 0.000316227766017 | 0.8204 | -0.03260 |
| MDA-MB-134-VI | BMS-265246 | 1.0 | 0.6431 | -0.03253 |
| SUM1315MO2 | AZD6738 | 0.1 | 1.2014 | -0.03250 |
| MDA-MB-134-VI | SHP099 | 0.316227766017 | 0.9169 | -0.03245 |
| MDA-MB-134-VI | Senexin B | 0.00316227766017 | 0.7387 | -0.03244 |
| MDA-MB-134-VI | THZ1 | 0.000316227766017 | 1.3638 | -0.03230 |
| MDA-MB-134-VI | SHP099 | 0.0316227766017 | 1.2841 | -0.03230 |
| MDA-MB-157 | GSK2334470 | 3.16227766017 | 0.6739 | -0.03220 |
| Hs 578T | THZ1 | 0.003162278 | 1.0492 | -0.03214 |
| MDA-MB-134-VI | SHP099 | 0.316227766017 | 0.9596 | -0.03206 |
| MDA-MB-134-VI | Ulixertinib | 0.001 | 1.1784 | -0.03199 |